Ponaxen (Ponatinib) is a targeted therapy medication primarily used for the treatment of specific types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Available in 15mg and 45mg dosages, Ponaxen is a potent tyrosine ...